BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 10958782)

  • 21. Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis.
    Vandenbroucke K; de Haard H; Beirnaert E; Dreier T; Lauwereys M; Huyck L; Van Huysse J; Demetter P; Steidler L; Remaut E; Cuvelier C; Rottiers P
    Mucosal Immunol; 2010 Jan; 3(1):49-56. PubMed ID: 19794409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice.
    Hanson ML; Hixon JA; Li W; Felber BK; Anver MR; Stewart CA; Janelsins BM; Datta SK; Shen W; McLean MH; Durum SK
    Gastroenterology; 2014 Jan; 146(1):210-221.e13. PubMed ID: 24120477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dextran sulphate sodium colitis in C57BL/6J mice is alleviated by Lactococcus lactis and worsened by the neutralization of Tumor necrosis Factor α.
    Berlec A; Perše M; Ravnikar M; Lunder M; Erman A; Cerar A; Štrukelj B
    Int Immunopharmacol; 2017 Feb; 43():219-226. PubMed ID: 28039805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral delivery of a Lactococcus lactis strain secreting bovine lactoferricin-lactoferrampin alleviates the development of acute colitis in mice.
    Song L; Xie W; Liu Z; Guo D; Zhao D; Qiao X; Wang L; Zhou H; Cui W; Jiang Y; Li Y; Xu Y; Tang L
    Appl Microbiol Biotechnol; 2019 Aug; 103(15):6169-6186. PubMed ID: 31165225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal delivery of Lactococcus lactis carrying an anti-TNF scFv expression vector ameliorates experimental colitis in mice.
    Chiabai MJ; Almeida JF; de Azevedo MGD; Fernandes SS; Pereira VB; de Castro RJA; Jerônimo MS; Sousa IG; de Souza Vianna LM; Miyoshi A; Bocca AL; Maranhão AQ; Brigido MM
    BMC Biotechnol; 2019 Jun; 19(1):38. PubMed ID: 31238939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant Lactococcus lactis expressing porcine insulin-like growth factor I ameliorates DSS-induced colitis in mice.
    Liu S; Li Y; Deng B; Xu Z
    BMC Biotechnol; 2016 Mar; 16():25. PubMed ID: 26932768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
    Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
    Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive Lactococcus lactis producing mycobacterial Hsp65 ameliorates intestinal inflammation in acute TNBS-induced colitis in mice by increasing the levels of the cytokine IL-10 and secretory IgA.
    da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
    J Appl Microbiol; 2020 Nov; 129(5):1389-1401. PubMed ID: 32473073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
    Chu CC; Hou YC; Pai MH; Chao CJ; Yeh SL
    J Nutr Biochem; 2012 Sep; 23(9):1092-9. PubMed ID: 22137260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular accumulation of trehalose protects Lactococcus lactis from freeze-drying damage and bile toxicity and increases gastric acid resistance.
    Termont S; Vandenbroucke K; Iserentant D; Neirynck S; Steidler L; Remaut E; Rottiers P
    Appl Environ Microbiol; 2006 Dec; 72(12):7694-700. PubMed ID: 17028239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory properties of fermented soy milk with Lactococcus lactis subsp. lactis S-SU2 in murine macrophage RAW264.7 cells and DSS-induced IBD model mice.
    Kawahara M; Nemoto M; Nakata T; Kondo S; Takahashi H; Kimura B; Kuda T
    Int Immunopharmacol; 2015 Jun; 26(2):295-303. PubMed ID: 25887264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactobacillus acidophilus Improves Intestinal Inflammation in an Acute Colitis Mouse Model by Regulation of Th17 and Treg Cell Balance and Fibrosis Development.
    Park JS; Choi JW; Jhun J; Kwon JY; Lee BI; Yang CW; Park SH; Cho ML
    J Med Food; 2018 Mar; 21(3):215-224. PubMed ID: 29336663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral Delivery of Mouse β-Defensin 14 (mBD14)-Producing
    Tian H; Li J; Chen X; Ren Z; Pan X; Huang W; Bhatia M; Pan LL; Sun J
    J Agric Food Chem; 2023 Apr; 71(13):5185-5194. PubMed ID: 36943701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected effect of probiotics by Lactococcus lactis subsp. lactis against colitis induced by dextran sulfate sodium in mice.
    Komaki S; Haque A; Miyazaki H; Matsumoto T; Nakamura S
    J Infect Chemother; 2020 Jun; 26(6):549-553. PubMed ID: 32122783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization.
    Frossard CP; Steidler L; Eigenmann PA
    J Allergy Clin Immunol; 2007 Apr; 119(4):952-9. PubMed ID: 17316776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amelioration of murine colitis by feeding a solution of lysed Escherichia coli.
    Konrad A; Mähler M; Flogerzi B; Kalousek MB; Lange J; Varga L; Seibold F
    Scand J Gastroenterol; 2003 Feb; 38(2):172-9. PubMed ID: 12678334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10-producing Lactococcus lactis using a murine model of Crohn's disease.
    del Carmen S; de Moreno de LeBlanc A; Perdigon G; Bastos Pereira V; Miyoshi A; Azevedo V; LeBlanc JG
    J Mol Microbiol Biotechnol; 2011; 21(3-4):138-46. PubMed ID: 22286041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation of colonic inflammation by partial replacement of dietary linoleic acid with α-linolenic acid in a rat model of inflammatory bowel disease.
    Tyagi A; Kumar U; Reddy S; Santosh VS; Mohammed SB; Ehtesham NZ; Ibrahim A
    Br J Nutr; 2012 Nov; 108(9):1612-22. PubMed ID: 22243775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10.
    Huyghebaert N; Vermeire A; Neirynck S; Steidler L; Remaut E; Remon JP
    Eur J Pharm Biopharm; 2005 Aug; 60(3):349-59. PubMed ID: 15927456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary Salt Exacerbates Experimental Colitis.
    Tubbs AL; Liu B; Rogers TD; Sartor RB; Miao EA
    J Immunol; 2017 Aug; 199(3):1051-1059. PubMed ID: 28637899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.